# Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

> **NCT06485089** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Obesity
- Breast Cancer Risk

## Interventions

- **DRUG:** tirzepatide

## Key facts

- **NCT ID:** NCT06485089
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-14
- **Primary completion:** 2026-02
- **Final completion:** 2026-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485089, "Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06485089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*